Background: Microvessel density (MVD) is a measure of the extent of new blo
od vessel growth or angiogenesis, which is required for tumor progression.
Increased MVD in primary breast cancers appears to adversely affect disease
-free survival and overall survival in patients with breast cancer. However
, the clinical implications of angiogenesis in breast cancer metastases hav
e not been well studied. The purpose of this study was to compare intratumo
ral MVD in primary breast cancer tissues with MVD in axillary lymph node me
tastases and to evaluate the relationships among primary- and metastatic-tu
mor MVD, disease-free survival, and overall survival in patients with lymph
node-positive, stage II breast cancer who were treated with adjuvant chemo
therapy in Cancer and Leukemia Group B Protocol 8082, Methods: Immunostaini
ng for factor VIII-related antigen was performed on tissue sections from 47
primary tumors and 91 axillary lymph nodes containing metastases from 110
patients with lymph node-positive breast cancer. Sections were examined for
the presence or absence of focal areas of relatively intense neovasculariz
ation (vascular hot spots), and a quantitative assessment of intratumoral M
VD was performed. Results: The presence of vascular hot spots in axillary l
ymph node metastases, but not primary breast cancers, was associated with s
tatistically significantly decreased disease-free survival (P = .006) and o
verall survival (P = .004) by univariate analysis. Similarly, increased MVD
in metastases, but not in primary tumors, was statistically significantly
associated with diminished overall survival in these patients (P = .02), In
multivariate analysis, the number of positive axillary lymph nodes and the
presence of vascular hot spots in axillary lymph node metastases predicted
decreased disease-free survival (P = .0001 and .02, respectively) and over
all survival (P = .0001 and .007, respectively). All P values were two-side
d. Conclusion: This pilot study suggests that assessing neovascularization
in axillary lymph node metastases may provide clinically useful information
regarding survival in patients with primary breast cancer.